Clinical Trial Update: Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy, safety and tolerability of atorvastatin 40 mg in patients with relapsing-remitting multiple sclerosis treated with interf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Relapsing-remitting Multiple Sclerosis | Phase 2 | Status: COMPLETED